nmol/l, respectively) and was followed by a moderately slow return of integrin to the surface. The results of the radioligand binding studies suggest that the binding of A20FMDV2 to the RGD-binding site on αvβ6 is required to maintain its engagement with the hypothesised A20FMDV2 synergy site on the integrin. In addition, there is evidence from flow cytometric studies that the RGD-ligand engagement of αvβ6 post-internalization plays a role in delaying recycling of the integrin to the cell surface. This mechanism may act as a homeostatic control of membrane αvβ6 following RGD ligand engagement.
Introduction
Integrins are heterodimeric, transmembrane glycoprotein receptors that have a primary function to act as signalling proteins in mammals [1] . They are composed of an α and β-subunit, of which in mammals there are 18 and 8 variants, respectively, that can form up to 24 heterodimers [2] . The α and β-subunits are bound in a noncovalent complex and their primary role is to act as adhesion receptors. In order to fulfill this role, they have the Key Words αvβ6 integrin · A20FMDV2 · Latency associated peptide-1 · Binding kinetics · Internalization kinetics Abstract A20FMDV2 is a peptide derived from the foot-and-mouth disease virus with a high affinity and selectivity for the alphav beta-6 (αvβ6) arginyl-glycinyl-aspartic acid (RGD)-binding integrin. It has been shown to be an informative tool ligand in pre-clinical imaging studies for selective labelling of the αvβ6 integrin in a number of disease models. In a radioligand binding assay using a radiolabelled form of the peptide ([ 3 H]A20FMDV2), its high affinity (K D : 0.22 nmol/l) and selectivity (at least 85-fold) for αvβ6 over the other members of the RGD integrin family was confirmed. [ 3 H]A20FMDV2 αvβ6 binding could be fully reversed only in the presence of EDTA, whereas a partial reversal was observed in the presence of excess concentrations of an RGD-mimetic small molecule (SC-68448) or unlabelled A20FMDV2. Using flow cytometry on bronchial epithelial cells, the ligand-induced internalization of αvβ6 by A20FMDV2 and latency-associated peptide-1 was shown to be fast (t 1/2 : 1.5 and 3.1 min, respectively), concentration-dependent (EC 50 : values 1.1 and 3.6 ability to signal in both directions across the plasma membrane, termed 'inside-out' signalling [3] , through binding to extracellular ligands and through cytoplasmic proteins binding to their intracellular domains.
The integrin family is split into sub-families based on a common α or β-subunit or related properties. The arginyl-glycinyl-aspartic acid (RGD) sub-family of integrins share an amino acid-binding motif (arginine (R), glycine (G) and aspartic acid (D)) in their endogenous ligands, with selectivity for these ligands determined by their surrounding amino acid sequences [4] . The RGD family of integrins includes the epithelial-restricted integrin alphav beta-6 (αvβ6) that was first identified in the early 1990s [5] and which demonstrates a high affinity for fibronectin, tenascin, latency-associated peptide-1 (LAP 1 ) and LAP 3 . In the epithelia of healthy adults, its expression is very low with the exception of the endometrium during the menstrual cycle [5] and diffuse expression associated with subclinical inflammation in the lung and kidney [6] . However, αvβ6 has been identified as being able to activate the transforming growth factor-β1 (TGFβ1) by binding to LAP on the constitutively expressed latent TGFβ1 [7] . Upon tissue injury, inflammation and cancer, the expression of this integrin is observed to be upregulated significantly. This has been shown in a range of diseases and organs that include acute lung injury and idiopathic pulmonary fibrosis (IPF) in the lung [8, 9] , fibrosis of the liver and kidney [10, 11] and carcinomas of the breast, lung, mouth, skin, colon, stomach and endometrium among others [12] . These observations, combined with additional data showing αvβ6 inhibition to have positive outcomes in pre-clinical models of fibrosis and cancer [9, 10, 13] , make this integrin a potential therapeutic target for these diseases where the normal control of TGFβ activation has become disrupted.
A20FMDV2 is a 20 amino acid peptide (NAVPNLRG DLQVLAQKVART; fig. 1 ) derived from the foot-andmouth disease virus (FMDV) with a high affinity and selectivity for the αvβ6 RGD integrin [14] . It has been shown to be an informative tool ligand in pre-clinical imaging studies for selective labelling of the αvβ6 integrin in a number of disease models [15] [16] [17] . Although the high affinity and selectivity of A20FMDV2 have been described previously [14] , an accurate determination of its association and dissociation binding kinetics with αvβ6 has not been fully defined and is addressed by this study using a radiolabelled form of the peptide ([ 3 H] A20FMDV2) to characterize these properties. In addition, while it is well established that A20FMDV2 induces internalization of the αvβ6 integrin [15, 16] , the kinetics of its return to the cell surface following ligandinduced internalization is less well described. To further explore this, a flow cytometric assay was developed using normal human bronchial epithelial (NHBE) cells to track αvβ6 location in a primary cell line that also allowed a direct comparison of the effects of A20FMDV2 with those of the endogenous αvβ6 ligand LAP 1 .
Materials and Methods
Materials SC-68448 [18] and cilengitide [19] H] determined by mass spectrometry and nuclear magnetic resonance). All other chemicals and reagents were purchased from Sigma-Aldrich Co. Ltd. (Gillingham, UK) unless otherwise stated. NHBE cells, growth medium and supplements were purchased from Lonza (Lonza Group Ltd., Basel, Switzerland). All other cell culture media and reagents were obtained from Invitrogen (Invitrogen Ltd., Paisley, UK). All tissue culture flasks and plates were purchased from Greiner Bio-One (Firckenhausen, Germany) unless otherwise stated. All antibodies used were commercially available and obtained from R&D Systems (Minneapolis, Minn., USA) unless otherwise stated and at a stock concentration of 10 μg/ml. For flow cytometry, these included phycoerythrin (PE) conjugated mouse IgG2B isotype control (IgG2B-PE) and PE-conjugated mouse monoclonal non-function blocking, antihuman integrin beta-6 (hβ6-PE) and for high content screening (HCS) mouse IgG2B isotype control (IgG2B-HCS), mouse monoclonal anti-human integrin beta-6 (hβ6-HCS) and Alexa Fluor 488 goat IgG anti-mouse Invitrogen (Invitrogen Ltd., Paisley, UK). Cellular assays and radioligand-binding assays were completed with a final dimethyl sulphoxide (DMSO) concentration of 0.1 and 1% respectively, unless otherwise stated. Purified soluble protein preparations for the human integrin proteins αvβ1, αvβ3, αvβ5, αvβ6, αvβ8, α5β1, α8β1 and αIIbβ3 were all purchased from R&D Systems Inc. (Minneapolis, Minn., USA) except for α8β1 that was generated by the Biological Sciences department at GSK Medicines Research Centre (Stevenage, UK).
NHBE Cell Culture
Frozen aliquots of NHBE cells were placed into culture as a monolayer adhered in type I collagen coated T75 or T175 cm 2 tissue culture flasks using aseptic techniques. Cells were maintained in NHBE cell medium (bronchial epithelial growth medium (BEGM TM ) containing 0.6 mmol/l MgCl 2 supplemented with BEGM TM Clonetics TM SingleQuots (containing bovine pituitary extract, insulin, hydrocortisone, GA-1000 (consisting of 30 mg/ml gentamicin and 15 μg/ml amphotericin), retinoic acid, transferrin, 116 triiodothyronine, epinephrine and human epidermal growth factor)) in 95: 5% air:CO 2 at 37 ° C and were harvested when ∼ 80% confluent using Accutase ® . Cells were then re-suspended in PBS, centrifuged at 300 g for 5 min prior to re-suspension in either NHBE cell medium or flow cytometry buffer (RPMI 1640 (without L-glutamine and phenol red) containing 10 mmol/l HEPES, 1% w/v bovine serum albumin and 2 mmol/l MgCl 2 ). Cells were then counted on a NucleoCounter NC-3000 (ChemoMetec, Allerød, Denmark) and re-suspended to the required cell density.
Radioligand Binding Studies
All radioligand-binding experiments were performed in 96-deep well plates at 37 ° C in binding buffer (25 mmol/l 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 100 mmol/l NaCl, 2 mmol/l MgCl 2 (unless otherwise stated) and 1 mmol/l 3-((3-cholamidopropyl)dimethylammonio)-1-propanesulfonate (CHAPS) at pH 7.4 (NaOH)). Radioligand binding studies were completed with recombinant soluble integrin proteins in a total volume of 0.5 ml consisting of 50 μl/well of either unlabelled compound at varying concentrations or vehicle (1% DMSO), 50 μl of [ 3 H]A20FMDV2 and 400 μl/well of purified integrin (0.3 or 2 nmol/l for αvβ6 and 2 nmol/l for αvβ1, αvβ3, αvβ5, αvβ8, α5β1, α8β1 and αIIbβ3).
Non-specific binding (NSB) was determined with either 10 μmol/l SC-68448 (pan-αv small molecule RGD-mimetic [18] ), 1 μmol/l A20FMDV2 or 10 mmol/l EDTA (chelating agent). Specific binding was measured by subtracting the NSB from the total radioligand binding in the presence of vehicle (1% DMSO). Plates were incubated with gentle agitation for the time periods indicated and binding terminated by rapid vacuum filtration through a 48-well Brandel harvester (Brandel Inc., Gaithersburg, Md., USA) onto GF/C filter papers pre-soaked in 0.3% v/v poly-ethylenimine. Samples were washed rapidly 3 times with ice cold distilled water (dH 2 O) and filters transferred into liquid scintillation (LS) vials containing 4 ml LS fluid (Ultima-Flo TM M, PerkinElmer LAS UK Ltd., Beaconsfield, UK). The amount of radioligand bound to integrin protein was measured by LS spectroscopy using a TriCarb 2900 TR LS counter (PerkinElmer LAS UK Ltd., Beaconsfield, UK). In order to determine the affinity of integrin ligands for the αvβ6 integrin, competition binding displacement studies were completed where αvβ6 integrin was incubated with a fixed concentration of [ 3 H]A20FMDV2 ( ∼ 2 nmol/l) and increasing concentrations of unlabelled test ligand for 6 h prior to filtration.
Flow Cytometric Analysis of αvβ6 Expression
All flow cytometry assays were performed in 96 well polypropylene microplates with NHBE cells suspended in flow cytometry buffer (45 μl/well with 70,000 cells/well) in the presence of 5 μl/well compound or vehicle (0.1% DMSO). Where stated, cells were permeabilised by incubating with 0.2% w/v saponin for 5 min at ambient temperature (20-22 ° C) prior to compound/vehicle addition. Inhibition of clathrin or lipid raft-mediated endocytosis was investigated by pre-incubating NHBE cells with either 2 μg/ml chlorpromazine or 10 μg/ml filipin [20] respectively, for 5 min prior to addition of compound or vehicle (0.1% DMSO). Experiments were stopped by the addition of 10 μl/well IgG2B-PE or hβ6-PE and transferring plates to 4 ° C for 1 h. Plates were then washed twice by centrifuging at 300 g for 5 min, removing supernatant and adding flow cytometry buffer (150 μl/well). After the second wash, cells were resuspended in flow cytometry buffer (200 μl/well) and cell suspensions transferred into a 96 well round bottom polypropylene plate (Corning Inc., Life Sciences, Tewksbury, Mass., USA). Cell samples were then acquired on a fluorescence activated cell sorting (FACS) Canto II (BD Biosciences, San Jose, Calif., USA) using a high throughput sampler system and BD FACS Diva TM version 6.1.3 software. Cells were identified by their forward and side-scatter characteristics and the mean fluorescence intensity (MFI) of antibody conjugated cells measured. The fluorescence was quantified on at least 5,000 cells and following acquisition, all data were exported as flow cytometry standard format 3.0 files with raw data values captured as MFI. Fluorescence-activated cell analyses histograms were plotted using FlowJo software (Tree Star Inc., Ashland, Oreg., USA).
For internalization concentration-response curves, NHBE cells were added to 96 well polypropylene microplates containing 5 μl/ well compound at varying concentrations or vehicle (0.1% DMSO). Plates were incubated for 2 h in 95: 5% air:CO 2 at 37 ° C prior to addition of 10 μl IgG2B-PE or hβ6-PE antibody. For determining the rate of ligand-induced αvβ6 internalization, NHBE cells were added to 96 well polypropylene microplates containing 5 μl/well compound (at a concentration that caused maximal internalization) or vehicle (0.1% DMSO). Plates were incubated in 95: 5% air:CO 2 at 37 ° C for varying times up to 1 h and then transferred immediately on to ice to stop any further internalization. IgG2B-PE or hβ6-PE (10 μl/well) antibody were then added to plates. For determining the rate of αvβ6 return to the cell surface (reversal of ligand-induced αvβ6 internalization), NHBE cells were added to 96 well polypropylene microplates containing 5 μl/well compound (at a concentration that caused maximal internalization) or vehicle (0.1% DMSO). Plates were incubated in 95: 5% air:CO 2 at 37 ° C for 1 h, then centrifuged at 500 g for 5 min, supernatant removed and cell pellets re-suspended in PBS (150 μl/well). This process was repeated prior to re-suspension of cells in cell medium (150 μl/well) and incubation for varying times up to 48 h. Plates were then transferred on to ice and 10 μl/well IgG2B-PE or hβ6-PE antibody added. All samples were then processed and read on the FACS Canto II as detailed earlier.
Data Analysis
Analysis of all experiments was completed using GraphPad Prism 5.0 (GraphPad Software, San Diego, Calif., USA). In order to allow the results between binding experiments to be averaged, where appropriate, disintegrations per minute (DPM) values were normalized to give the amount (in femtomoles as calculated by the methods previously described [21] ) of radioligand bound per amount (ng) of purified protein (fmol/ng).
Specific binding data from association binding experiments were fitted globally to the association kinetic model (Equation 1, where K ob is the observed rate constant of the association reaction, k on is the association rate constant in units of inverse molar time inverse time (mol/l -1 ·min -1 ) and k off is the dissociation rate constant in inverse units of time (min -1 )). From Equation 1, K ob values were subsequently used to calculate association half-life (t 1/2 ) values at fixed radioligand concentrations using the equation t 1/2 = 0.693/K ob .
To calculate the percentage of radioligand bound in dissociation binding studies at each time point, Equation 2 was used (where TB is total binding of radioligand determined in the presence of vehicle (1% DMSO). Binding is the level of binding observed in test well and NSB is non-specific binding determined in the presence of either excess unlabelled ligand or EDTA, all measured at the same time point in DPM).
(2) Dissociation binding data were fitted to a one-phase dissociation model (Equation 3, where k off is the dissociation rate constant in inverse units of time (min -1 ) and NSB t = ∞ is non-specific binding determined at infinite time). 118 Specific binding data from saturation experiments were fitted to a one affinity site model (Equation 4 , where n H is the Hill coefficient and K is the mid-point of the binding isotherm) where appropriate to determine K D . For visualisation only, specific binding data from saturation experiments were also analysed via Scatchard transformation [22] using the method previously described [21] . (4) All concentration response curves and competition binding displacement curves were fitted using non-linear regression analysis (4-parameter logistic equation with variable slope [23] ) with EC 50 or IC 50 values calculated from the fits. Measurement of the β6 integrin subunit via hβ6-PE binding in flow cytometric assays was used as a surrogate for tracking the location of the αvβ6 heterodimer and for ligand-induced internalization concentration response curves, data were expressed as % internalized αvβ6 using Equation 7 (where x represents the MFI of hβ6-PE staining in the absence of compound, y represents the MFI of hβ6-PE staining in the presence of compound and z represents the MFI of isotype control (IgG2B-PE) staining). (7) For rates of ligand-induced internalization and subsequent recycling of β6, data were expressed as % αvβ6 surface expression using Equation 8 (where % αvβ6 SE is the % αvβ6 surface expression, x represents the MFI of hβ6-PE staining in the absence of compound, y represents the MFI of hβ6-PE staining in the presence of compound and z represents the MFI of isotype control (IgG2B-PE) staining).
(8)
The ligand-induced β6 internalization data for compounds were fitted to a one-phase decay model (Equation 9 , where % αvβ6 SE is the % αvβ6 surface expression, k in is the internalization rate constant in inverse units of time (min -1 ) and % αvβ6SE t = ∞ is % αvβ6 surface expression determined at infinite time). Internalization half-life (t 1/2 ) values were calculated using the equation t 1/2 = 0.693/k in . (9) For statistical analyses, differences of p < 0.05 were considered to be statistically significant. For determination of statistical difference between a single data set and a hypothetical value, a onesample t test was carried out. Statistical significance between 2 data sets was tested using a Student's unpaired t test. One-way analysis of variance (ANOVA) was used for comparison of more than 2 datasets. Unless otherwise indicated, data shown graphically and in the text are either mean ± SD or, where 3 or more data points/ individual experiments have been completed, mean ± SEM.
Results

Characterisation of the Binding of [ 3 H]A20FMDV2 with the αvβ6 Integrin
In kinetic binding studies, the association of , Mg 2+ and Mn 2+ able to support binding ( fig. 3 a) 3 H]A20FMDV2 due to the inability to test at concentrations above 50 nmol/l) caused inhibition of radioligand binding to NSB levels ( fig. 3 b) . The pK I value determined for the unlabelled A20FMDV2 was not significantly different to the pK D value determined in saturation binding studies with A20FMDV2 (Student's unpaired t test, p > 0.05).
RGD Ligand-Induced Internalization of αvβ6
To quantitatively measure the surface (membrane) and total (membrane and intracellular pools) NHBE cell expression of αvβ6, flow cytometric assays were completed using hβ6-PE to measure the β6 subunit as a surrogate for the heterodimer (β6 does not pair with any other α integrin subunit). To validate the use of flow cytometry to measure internalization of αvβ6, the endogenous ligand fLAP 1 was tested in the absence and presence of 0.2% w/v saponin to investigate surface and total cell integrin populations respectively. In the absence of saponin, a significant reduction in the surface expression of the β6 subunit was observed in the presence of fLAP 1 ( fig. 4 a (panel 2 ) and b) (ANOVA, Bonferroni post test, p < 0.05) with MFI values not significantly different from those in the presence of IgG2B-PE isotype control (ANOVA, Bonferroni post test, p > 0.05). When cells were permeabilised in the presence of saponin to allow antibodies intracellular access, there was no significant difference observed between hβ6-PE with and without fLAP 1 (ANOVA, Bonferroni post test, p > 0.05) ( fig. 4 a (panel 4) and b) . In addition, 0.2% w/v saponin (concentration used to permeabilise NHBE cells) did not reduce the affinity of tLAP 1 for the αvβ6 integrin in a radioligand competition binding assay (data not shown). Based on the MFI values for hβ6-PE in permeabilised (total cell staining) and unpermeabilised (membrane staining) NHBE cells in the presence of 0.1% DMSO, ∼ 36% of αvβ6 integrin was present intracellularly and ∼ 64% at the cell surface. The internalization observed in the presence of fLAP 1 was significantly inhibited when NHBE cells were pre-incubated with the clathrincoated pits inhibitor chlorpromazine (ANOVA, Bonferroni post test, p < 0.05), while the lipid rafts inhibitor filipin had no effect ( fig. 5 ) .
Kinetics of RGD Ligand-Induced αvβ6
Internalization fLAP 1 and A20FMDV2 both caused concentration-dependent, ligand-induced αvβ6 internalization following a 2 h incubation with NHBE cells ( fig. 6 a) . The pEC 50 values for internalization of αvβ6 by fLAP 1 and A20FMDV2 were 8.45 ± 0.07 and 9.01 ± 0.13 respectively (mean ± SEM, n = 4). To determine the rates of ligand-induced internalization, the surface expression of αvβ6 was measured over time following the addition of a maximal concentration of fLAP 1 or A20FMDV2, as determined in concentration response studies. Both RGD ligands caused a rapid internalization of αvβ6 (fLAP 1 t 1/2 3.1 ± 0.8 and A20FMDV2 t 1/2 1.5 ± 0.6 min (mean ± SEM, n = 4) with no significant difference observed between t 1/2 (Student's unpaired t test, p > 0.05)). A maximal loss of 79 and 80% cell surface integrin was observed for fLAP, and A 20FMDV2 respectively, over the 1 h time course studied ( fig. 6 b) . To measure the return of αvβ6 to the surface Effect of clathrin-coated pits and lipid rafts disrupting agents on fLAP 1 -induced αvβ6 internalization. Inhibition of clathrin or lipid raft-mediated endocytosis was investigated by pre-incubating NHBE cells with either 2 μg/ml chlorpromazine or 10 μg/ml filipin respectively, for 5 min prior to addition of fLAP 1 or control (0.1% DMSO) for a 2 h incubation. β6 integrin staining was then determined by flow cytometry where NHBE cells were washed and stained with either a PE-conjugated mouse IgG2B isotype control (IgG2B-PE) or a PE-conjugated mouse monoclonal anti-human integrin β6 (hβ6-PE). Significant differences between test groups denoted by * * p < 0.01 (ANOVA, Bonferoni's posttest). Data shown are the mean ± SEM of 3 individual experiments carried out in duplicate. n.s. = Not significant.
membrane, washout studies were completed where a maximal concentration of fLAP 1 (60 nmol/l) or A20FMDV2 (1 μmol/l) was incubated with NHBE cells for 1 h followed by the removal of αvβ6 ligand and washing of cells in PBS twice. Cells were then incubated for increasing time periods of up to 48 h and surface expression of αvβ6 measured at different intervals by flow cytometry. The rate of return of αvβ6 to the cell surface was moderately slow post-washout of both RGD-ligands with 58 and 61% of the total integrin returned to the surface at 48 h, still internalized at 4 h ( fig. 6 b) for A20FMDV2 and fLAP 1 .
Discussion
With the FMDV-derived peptide A20FMDV2 demonstrating such a high affinity and selectivity for αvβ6, it has been used to great effect as a tool in the diagnosis of cancer, especially as a radiotracer for in vivo imaging studies investigating αvβ6 expression in tumours [14, 15] . In this study, A20FMDV2 has been used as tool peptide for comparison with the endogenous αvβ6 ligand LAP 1 . A number of characteristics of A20FMDV2 demonstrated in previously published studies have been confirmed here with the use of a [
3 H] labelled form of the peptide. For example, the high affinity and selectivity of A20FMDV2 for the αvβ6 integrin have been confirmed; in addition to this, the αvβ6-binding kinetics for the peptide has also been demonstrated. Previously published data suggested that A20FMDV2 forms an EDTA-resistant complex with αvβ6, but only if the peptide-integrin complex is pre-formed [25] . It was shown that after 30 min in the presence of an excess of unbiotinylated A20FMDV2, binding could not be reversed from the pre-formed biotinylated A20FMDV2-αvβ6 complex. For comparison in this study, full dissociation profiles over a 24 h time course were generated for [ 3 H] A20FMDV2, investigating a number of methods to initiate radioligand dissociation. These included the sequestering of divalent metal cations (required for RGD binding [2] ) with EDTA and competition with excess unlabelled ligands (both an RGD small molecule binder (SC-68448) and unlabelled A20FMDV2). Over this extended timeframe, EDTA was able to reverse the binding of [ binding to αvβ6 was observed by Dicara et al. [25] , whereas in this study ∼ 50% of [ 3 H]A20FMDV2 is unbound at this time point. These previously published experiments were completed at 4 ° C. However, in contrast, all binding experiments in this study were completed at 37 ° C and therefore, an explanation for this could be that the slower kinetics at the low temperature conditions resulted in A20FMDV2 dissociation not being detected at the 30 min time point. When dissociation of [ 3 H]A20FMDV2 from αvβ6 was initiated by either an RGD small molecule RGDmimetic (SC-68448) or an unlabelled A20FMDV2 in this study, only a partial reversal of radioligand binding could be achieved up to 24 h. This may provide further evidence for the so-called 'synergy site' that has been proposed for the interaction of RGD-containing peptides with a number of integrins [26, 27] , including αvβ6 [28] , whereby an interface between the secondary structure of the peptide stabilises the RGD site binding. This is supported by direct competition at the RGD binding site with SC-68448 not being sufficient to fully reverse the binding of A20FMDV2 to the αvβ6 integrin. Interestingly, the unlabelled A20FMDV2 is also unable to compete with the second site that may suggest it is not structurally in the correct conformation to achieve this unless first bound to the RGD-binding site. In agreement with this suggestion, Dicara et al. [25] reported that A20FMDV2 remains unstructured in solution and only assumes 2D and 3D conformation after integrin binding. The full reversal of [ show that if the peptide competes with unlabelled αvβ6 ligands at the same time, that is, if it is not allowed to form a complex with αvβ6, all the radioligand can be competed off to NSB levels.
The regulation of ligand binding to integrins has been shown to be dependent on divalent cations due to the presence of allosteric cation-binding sites within their protein structure [29, 30] suggested that there was a mixed αvβ6 integrin population in the soluble protein preparation either in the low-or high-affinity state that could be activated with greater efficiency by this divalent cation [30] .
The αvβ3 small molecule RGD-mimetic SC-68448 has been shown in this study to bind to αvβ6 with moderately high affinity, not previously demonstrated, and has provided a useful tool for characterizing the interaction between [ 3 H]A20FMDV2 and αvβ6. This observation suggests that SC-68448 is potentially a pan-αv integrin RGD-mimetic rather than an αvβ3-selective molecule and may provide a useful tool for probing the other members of the RGD integrin family. In addition, it has been shown that a truncated version of LAP 1 (containing the RGD-binding motif and flanking amino acids) has a comparable affinity for the αvβ6 integrin compared with the full length LAP 1 . Although the n H for full length LAP 1 was steeper (>1), this is likely a result of being unable to define a complete competition binding curve under the constraints on the highest concentration that could be achieved with the full length protein (50 nmol/l). Therefore, the truncated form of LAP 1 also provides an attractive tool for probing the selectivity profile of LAP 1 at the other RGD integrins, as concentrations up to high μmol/l could be investigated. This would be extremely useful to understand, as it could highlight which other TGFβ-activating RGD integrins may be relevant in diseases such as IPF and cancer.
It has been demonstrated that internalization of the integrin occurs following the binding of selective peptides (derived from the human foot-and-mouth virus) to αvβ6 [15, 16] . In this study, flow cytometry was used to measure the surface expression of αvβ6 and its subsequent loss post-addition of ligand. Although this technique has not been used routinely for measuring ligandinduced internalization of integrins, it has been used successfully in the G-protein-coupled receptor field investigating agonist and antagonist-induced internalization and recycling of the CCR4 receptor [31, 32] . A human anti-β6 antibody was used to measure the spatial location of the β6 integrin subunit as a marker for αvβ6. This was chosen in favour of using anti-αvβ6 antibodies, as these could bind either orthosterically (at the RGDsite) or allosterically (site distinct from RGD-site) and both would have the potential to compete with αvβ6 ligands. Orthosteric antibodies would also have the potential to induce internalization [33] , thus making the mea-surement of ligand-induced internalization with these antibodies not possible. Even though the antibody used for flow cytometry in this study was designated as anti-β6, it was still confirmed not to bind and compete with the αvβ6 integrin (online suppl. fig. S1 , see www.karger.com/ doi/10.1159/000443180). The inferred ligand-induced internalization observed for fLAP 1 in flow cytometry was abolished in the presence of saponin. Saponin permeabilises the plasma cell membrane by forming complexes with cholesterol to generate pores [34] that would allow the antibody to access the intracellular pool of αvβ6. This not only acted as an additional control to confirm fLAP 1 was not competing with the anti-β6 antibody, but control data also showed the total cell αvβ6 levels relative to the surface level allowing a measurement of intracellular αvβ6, with ∼ 64% of integrin present at the cell surface and ∼ 36% located intracellularly. In addition, it was shown that the αvβ6 internalization in the NHBE system was being driven by a clathrin-dependent mechanism, which agrees with published data where this endocytic mechanism was linked to the αvβ6 integrin [35] .
A20FMDV2 demonstrated a higher potency for αvβ6 internalization compared with fLAP 1 , with a comparable difference to that observed with the affinity estimates in radioligand binding studies. The endogenous internalization and recycling of the αvβ6 integrin has been shown to occur very quickly and within 30 min [35, 36] . However, less is known regarding ligand-induced αvβ6 internalization and the subsequent return of the integrin back to the cell surface. In this study, the rate of internalization was determined for A20FMDV2 and fLAP 1 with both shown to internalise αvβ6 very quickly and with comparable t 1/2 values that were measured within minutes of ligand addition. Furthermore, they both caused a comparable level of αvβ6 internalization ( ∼ 80% when normalised to isotype control). The more interesting observations in this study were the time of return of αvβ6 post-washout of ligand. Both RGD-peptides post-washout had a comparable profile with ∼ 40 or 50% (for fLAP 1 and A20FMDV2 respectively) of the total integrin returned to the surface at 48 h, still internalized at 4 h. The recycling observed in these studies, compared with that of endogenous turnover of αvβ6, is slower, suggesting that the internalised ligand-αvβ6 complex return to the cell surface is being delayed by the RGD-ligand interaction. This is comparable to the mechanism by which α5β1 recycling is dependent on the activation state of the integrin [37] as a result of RGD-ligand engagement.
In summary, this study has confirmed A20FMDV2's high affinity and selectivity for αvβ6 using radioligand binding and has shown it exhibits a complex interaction with the integrin post-RGD site binding. The full dissociation of [ 3 H]A20FMDV2 from αvβ6 observed in the presence of EDTA, compared with partial dissociation in the presence of RGD-ligands, suggests that the direct A20FMDV2/αvβ6 synergy site binding either requires the presence of metal divalent cations to maintain engagement or is dependent on the initial RGD-binding site interaction. As it is well established that divalent metal cations are required for RGD site binding, it is likely that the latter mechanism is responsible for maintaining the synergy site interface. Therefore, the difference observed between EDTA and direct RGD-ligand competition in dissociation studies is potentially due to removal of metal divalent cations being able to disengage A20FMDV2 from the RGD site fully, while RGD ligands are unable to fully access and dissociate the peptide's RGD interaction post-formation of the tight A20FMDV2-αvβ6 complex.
In conclusion, the internalization of αvβ6 by its endogenous ligand LAP 1 has been demonstrated for the first time and its profile is comparable to that observed with A20FMDV2, whereby a fast internalization rate is followed by a moderately slow return of integrin to the surface. This potentially suggests that the RGD-ligand interaction intracellularly plays a role in delaying αvβ6 recycling to the cell surface acting as a mechanism to control subsequent RGD ligand engagement. In addition, this is the first study to characterise the RGD-ligand induced internalization of αvβ6 in normal human epithelial cells that stands as a benchmark for comparison with diseased cells from fibrotic and cancer tissues in future studies.
